These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25079952)

  • 21. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
    Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F; Jergova S; Pearson JP; Sagen J
    Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
    Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
    Kramer JS; Woltersdorf S; Duflot T; Hiesinger K; Lillich FF; Knöll F; Wittmann SK; Klingler FM; Brunst S; Chaikuad A; Morisseau C; Hammock BD; Buccellati C; Sala A; Rovati GE; Leuillier M; Fraineau S; Rondeaux J; Hernandez-Olmos V; Heering J; Merk D; Pogoryelov D; Steinhilber D; Knapp S; Bellien J; Proschak E
    J Med Chem; 2019 Sep; 62(18):8443-8460. PubMed ID: 31436984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.
    Crowe MS; Wilson CD; Leishman E; Prather PL; Bradshaw HB; Banks ML; Kinsey SG
    Br J Pharmacol; 2017 Dec; 174(23):4523-4539. PubMed ID: 28963716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.
    Inceoglu B; Wagner K; Schebb NH; Morisseau C; Jinks SL; Ulu A; Hegedus C; Rose T; Brosnan R; Hammock BD
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5093-7. PubMed ID: 21383170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.
    Inceoglu B; Jinks SL; Schmelzer KR; Waite T; Kim IH; Hammock BD
    Life Sci; 2006 Nov; 79(24):2311-9. PubMed ID: 16962614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
    Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.
    Hammock BD; McReynolds CB; Wagner K; Buckpitt A; Cortes-Puch I; Croston G; Lee KSS; Yang J; Schmidt WK; Hwang SH
    J Med Chem; 2021 Feb; 64(4):1856-1872. PubMed ID: 33550801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
    Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
    Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase.
    Lee KS; Morisseau C; Yang J; Wang P; Hwang SH; Hammock BD
    Anal Biochem; 2013 Mar; 434(2):259-68. PubMed ID: 23219719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gabapentin for Chronic Neuropathic Pain.
    Moore A; Derry S; Wiffen P
    JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervertebral Foramen Injection of Ozone Relieves Mechanical Allodynia and Enhances Analgesic Effect of Gabapentin in Animal Model of Neuropathic Pain.
    Luo WJ; Yang F; Yang F; Sun W; Zheng W; Wang XL; Wu FF; Wang JL; Wang JS; Guan SM; Chen J
    Pain Physician; 2017 Jul; 20(5):E673-E685. PubMed ID: 28727712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.